‘Revolution’ Quelled? FDA Warns Firm For ReLuma Stem-Cell Claims
This article was originally published in The Rose Sheet
Executive Summary
Claims promoting Cell Vitals’ ReLuma skin-care line render the products unapproved drugs, FDA asserts in a Nov. 24 warning letter. Marketed as “A Revolution in Stem Cell Skin Care,” the firm’s products feature cytokines and growth factors harvested from adult stem cells that send “grow and divide” signals to aging skin cells, the company says.
You may also be interested in...
AIVITA Stem Cell Skin Care; Scent Republik Fragrance Stiks For Tweens; More Cosmetics Product News
AIVITA Biomedical plans to support its clinical cancer development programs with revenue from a skin-care line featuring its proprietary stem cell technology; Scent Republik, founded by two dads as a fresh take on kid's cosmetics, launches fragrance "stiks." More news in brief.
FDA Warns Another 'Stem Cell' Skin Care Marketer On Drug Claims
Stem cell-related claims on cosmetics may capture consumers' imagination, but they are grabbing FDA's attention as well. Hollywood Skincare International, which markets its DermaSet Stem Cell 3D Renewal cream online, is the latest player in this game to receive a warning letter from the agency.
FDA Warns Another 'Stem Cell' Skin Care Marketer On Drug Claims
Stem cell-related claims on cosmetics may capture consumers' imagination, but they are grabbing FDA's attention as well. Hollywood Skincare International, which markets its DermaSet Stem Cell 3D Renewal cream online, is the latest player in this game to receive a warning letter from the agency.